Vincemt Lee

Dr. Vincemt Lee


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2006 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
VLVincemt Lee
Vincemt Lee
PCPik Shun Mrcp Cheng
Pik Shun Mrcp Cheng
KCKi Wai Mrcp Chik
Ki Wai Mrcp Chik
GWGary W. K. Frcpc Wong
Gary W. K. Frcpc Wong
MSMatthew M. K. Frcp Shing
Matthew M. K. Frcp Shing
CLChi Kong Frcp Li
Chi Kong Frcp Li
We describe two pediatric patients who developed autoimmune hypothyroidism 2 years after unrelated allogeneic hematopoietic stem cell transplantation. The causes of post-transplantation autoimmune hypothyroidism are probably multiple. In these two patients, the presence of chronic graft-versus-host disease may be the most significant contributing factor.

28 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
CMChristy Yuen-Kwan Mak
Christy Yuen-Kwan Mak
DKDennis TL Ku
Dennis TL Ku
ALAnthony Pak-Yin Liu
Anthony Pak-Yin Liu
VLVincemt Lee
Vincemt Lee
JYJeffrey PW Yau
Jeffrey PW Yau
ECEugene YH Chan
Eugene YH Chan
Background: The long-term kidney outcomes in paediatric osteosarcoma survivors treated with nephrotoxic chemotherapeutic agents are not well-described. Methods: We conducted a multi-centre retrospective cohort study and recruited paediatric osteosarcoma survivors who survived beyond 5 years from cancer diagnosis over a 20-year period. Chronic kidney disease (CKD) was defined as evidence of kidney impairment, chronic tubulopathy, and proteinuria upon last follow-up. Results: We included 89 patients (57% males) with a mean follow-up period of 14.9 years. A total of 42 subjects (47.2%) developed CKD, 28 of whom had CKD stage 1 with either chronic tubulopathy or proteinuria; 14 patients had CKD stage 2 (eGFR < 90 mL/min/1.73 m2), while two had CKD stage 3 (eGFR < 60 mL/min/1.73 m2). Chronic tubular dysfunction was reported in 34 patients (38%), with hypomagnesemia being the most common manifestation. Proteinuria and hypertension were infrequently observed, in 3% and 8% of cases, respectively. We found that a history of severe AKI and aminoglycoside exposure during the treatment course were significant risk factors for CKD, but the dose-dependent relationships between the development of CKD and cisplatin, ifosfamide, and methotrexate could not be demonstrated. Conclusions: CKD is prevalent among paediatric osteosarcoma survivors. Caution is needed when using multiple nephrotoxic agents at the same time, as this could increase the risk of CKD in the long run. Multi-disciplinary regular surveillance should be performed to identify and manage CKD early, including kidney function, electrolyte, and proteinuria monitoring.